[1]汪晓玲　倪志福　王云甫.依达拉奉联合氯吡格雷治疗老年缺血性脑卒中的效果与安全性分析[J].中国临床神经外科杂志,2017,(04):222-223,285.[doi:10.13798/j.issn.1009-153X.2017.04.005]
　WANG Xiao-ling,NI Zhi-fu,WANG Yun-fu..Curative effect of edaravone combined with clopidogrel on ischemic stroke and its safety in the elderly patients[J].,2017,(04):222-223,285.[doi:10.13798/j.issn.1009-153X.2017.04.005]
点击复制

依达拉奉联合氯吡格雷治疗老年缺血性脑卒中的效果与安 全性分析()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2017年04期
页码:
222-223,285
栏目:
论著
出版日期:
2017-04-25

文章信息/Info

Title:
Curative effect of edaravone combined with clopidogrel on ischemic stroke and its safety in the elderly patients
文章编号:
1009-153X（2017）04-0222-02
作者:
汪晓玲　倪志福　王云甫
442000 湖北，十堰市太和医院（湖北医药学院附属医院）神经内科（汪晓玲、王云甫），小儿外科（倪志福）
Author(s):
WANG Xiao-ling1;  NI Zhi-fu2;  WANG Yun-fu1.
1. Department of Neurology, Taihe Hospital, Hubei College of Medicine, Shiyan 442000, China;
2. Department of Pediatric Surgery, Taihe Hospital, Hubei College of Medicine, Shiyan 442000, China
关键词:
缺血性脑卒中; 依达拉奉; 氯吡格雷; 老年; 疗效; 安全性
Keywords:
Ischemic stroke;  Edaravone;  Clopidogrel;  Elderly patients;  Curative effects;  Safety
分类号:
R 743
DOI:
10.13798/j.issn.1009-153X.2017.04.005
文献标志码:
A
摘要:
目的 探讨依达拉奉联合氯吡格雷治疗老年缺血性脑卒中的效果与安全性。方法 2014年1月到2016年5月前瞻性收治老年缺血性脑卒中160例，按随机信封抽签原则分为观察组与对照组，各80例；对照组给予口服氯吡格雷治疗，观察组在对照组治疗的基础上加用依达拉奉注射液治疗。结果 治疗2周后，观察组总有效率（93.8%）明显高于对照组（75.0%；P<0.05）。治疗2周后，两组血清白介素-6（IL-6）和肿瘤坏死因子-α（TNF-α）水平均明显低于治疗前（P<0.05），而且，观察组血清IL-6和TNF-α水平均明显低于对照组（P<0.05）。治疗2周后，观察组与对照组的生存质量评分为都明显高于治疗前（P<0.05），且观察组明显高于对照组（P<0.05）。治疗后90 d，观察组症状性脑出血发生率（0%）与非症状性脑出血发生率（1.3%）均明显少于对照组（分别为12.5%和12.5%；P<0.05）。结论 依达拉奉联合氯吡格雷治疗老年缺血性脑卒中能提高疗效，其机制可能与抑制机体炎症因子的表达有关。
Abstract:
Objective To investigate the curative effect of edaravone combined with clopidogrel on ischemic stroke and its safety in elderly patients. Methods One hundred and sixty elderly patients with ischemic stroke treated in our hospital from January, 2014 to May, 2016 were randomly divided into two groups, i.e. control group in which the patients (n=80) were treated by clopidogrel after the thrombolysis and observed group in which the patients were treated by edaravone combined with clopidogrel after thrombolysis. The serum levels of IL-6 and tumor necrosis factor α (TNF-α) were determined in all the patients before and 2 weeks after the treatment. The prognoses and safety were compared between both the groups. Results The effective rate (93.8%) was significantly higher in the observed group than that (75.0%) in the control group (P<0.05). The serum levels of IL-6 and TNF-α were significantly lower after the treatment than those before the treatment in the two groups (P<0.05), and the serum levels of IL-6 and TNF-α in the observed group were significantly lower than those in the control group after the treatment (P<0.05). The life quality scores were significantly higher after the treatment than those before the treatment in the observed and the control groups (P<0.05). The life quality scores were significantly higher in the observed group than those in the control group after the treatment (P<0.05). The incidence of symptomatic cerebral hemorrhage and non symptomatic cerebral hemorrhage were significantly lower in the observed group than those in the control group after the treatment (P<0.05). Conclusions That the curative effect and life quality can be improved and the complications can be decreased by the application of edaravone combined with clopidogrel in the elderly patients with ischemic stroke may be related to the inhibition of serum inflammatory factors expressions including IL-6 and TNF-α.

参考文献/References:

[1] Ke J, Jing M. Analysis of treatment effect of urinary kalli- dinogenase combined with edaravone on massive cerebral infarction [J]. Biomed Rep, 2016, 5(2): 155-158.
[2] 王　娜，赵荣生，孙路路. 缺血性脑卒中住院病人用药分 析及其临床路径用药推荐[J]. 临床药物治疗杂志，2016， 14（2）：44-47.
[3] 牛　犇，牛　思. 氯吡格雷治疗急性缺血性脑卒中的疗效 及对血浆大内皮素-1和血清脂蛋白-α的影响[J]. 中国卫 生标准管理，2016，7（9）：82-83.
[4] 张松林. 还原型谷胱甘肽联合依达拉奉注射液治疗急性 脑梗死[J]. 中国实用医刊，2015，42（17）：102-103.
[5] 夏长伟. 依达拉奉在心血管疾病中应用研究进展[J]. 中华 实用诊断与治疗杂志，2016，30（4）：328-330.
[6] Hoffmann CJ, Harms U, Rex A, et al. Vascular signal trans- ducer and activator of transcription-3 promotes angioge- nesis and neuroplasticity long-term after stroke [J]. Circula- tion, 2015, 131(20): 1772-1782.
[7] 任宏伟，茅利玉，钱　华. 舒血宁注射液联合小牛血去蛋 白提取物对脑梗死恢复期病人血清IGF-1、IL-1及 ICAM-1水平影响研究[J]. 中国生化药物杂志，2015，11 （9）：133-135.
[8] 王英兆. 门诊缺血性卒中病人抗血小板聚集治疗临床分 析[J]. 内科，2016，11（1）：58-59，6.
[9] 郑壮辉，龚　煜，王　兵. 阿司匹林联合氯吡格雷在缺血 性脑卒中中的应用[J]. 中国现代药物应用，2016，10（7）： 136-137.
[10] 刘志君，黄汉烽. 氯吡格雷联合阿司匹林对进展性缺血性 脑卒中病人神经功能及生活能力的影响[J]. 中国药物经 济学，2016，11（5）：41-43.
[11] 王丽平，张新宇，樊东升，等. 脑出血病人服用抗血小板药 物的长期随访研究[J]. 中国医学前沿杂志（电子版）， 2016，8（2）：81-84.
[12] 李　琳，张临洪，徐武平. 氯吡格雷联合奥扎格雷钠治疗 后循环脑梗死的临床疗效观察[J]. 中国临床神经外科杂 志，2010，15（8）：474-476.

相似文献/References:

[1]郑俊华　唐浩然　景丽英　罗琼珍　高晓峰.依达拉奉联合丙泊酚治疗急性脑梗死的疗效观察[J].中国临床神经外科杂志,2015,(08):489.[doi:10.13798/j.issn.1009-153X.2015.08.016]
[2]张　斌　钱春生.依达拉奉对重型颅脑损伤患者血浆8-iso-PGF2α水平的影响及其临床疗效观[J].中国临床神经外科杂志,2015,(03):153.[doi:10.13798/j.issn.1009-153X.2015.03.008]
　ZHANG Bin,QIAN Chun-sheng..Effect of edaravone on plasma level of 8-iso-prostaglandin-F2α and prognosis in patients with severe craniocerebral trauma[J].,2015,(04):153.[doi:10.13798/j.issn.1009-153X.2015.03.008]
[3]宋　平　陈晓斌　杜　浩　蔡　强　罗　明　阮　航　吴京雷　段发亮.内膜斑块剥脱术治疗颈动脉狭窄的临床分析[J].中国临床神经外科杂志,2016,(09):527.[doi:10.13798/j.issn.1009-153X.2016.09.006]
　SONG Ping,CHEN Xiao-bin,DU Hao,et al.Clinical analysis of carotid endarterectomy for ischemic stroke[J].,2016,(04):527.[doi:10.13798/j.issn.1009-153X.2016.09.006]
[4]段发亮,黄从刚,倪厚杰,等.阿司匹林联合氯吡格雷治疗缺血性脑卒中的疗效及对血小板聚集率的影响[J].中国临床神经外科杂志,2017,(07):470.[doi:10.13798/j.issn.1009-153X.2017.07.008]
　DUAN Fa-liang,HUANG Cong-gang,NI Hou-jie,et al.Curative effect of aspirin combined with plavix on ischemic stroke and its impact on platelet aggregation rate[J].,2017,(04):470.[doi:10.13798/j.issn.1009-153X.2017.07.008]
[5]贺　峰　马仁政.穿刺引流术联合依达拉奉治疗高血压性脑出血的疗效[J].中国临床神经外科杂志,2017,(09):648.[doi:10.13792017.09/j.issn.1009-153X.2017.09.013]
[6]王谋龙　李爱红　曲良锁.血清ANP水平及ANP基因多态性与缺血性脑卒中相关性的Meta分析[J].中国临床神经外科杂志,2018,(03):161.[doi:10.13798/j.issn.1009-153X.2018.03.007]
　WANG Mou-long,LI Ai-hong,QU Liang-suo.Meta-analysis of relativity of ANP serum levels and genetic polymorphisms with ischemic stroke risk[J].,2018,(04):161.[doi:10.13798/j.issn.1009-153X.2018.03.007]
[7]徐东为　赵振伟　李　江　闫忠军　屈　延　高国栋.急性前循环脑动脉闭塞支架成形术的疗效[J].中国临床神经外科杂志,2018,(05):328.[doi:10.13798/j.issn.1009-153X.2018.05.008]
　XU Dong-wei,ZHAO Zhen-wei,LI Jiang,et al.Effect of stenting on acute cerebral artery occlusion in anterior circulation[J].,2018,(04):328.[doi:10.13798/j.issn.1009-153X.2018.05.008]
[8]陈　旭　杨　旭.依达拉奉联合神经生长因子治疗重型颅脑损伤的疗效分析[J].中国临床神经外科杂志,2018,(07):479.[doi:10.13798/j.issn.1009-153X.2018.07.009]
　CHEN Xu,YANG Xu..Effect of edaravone combined with nerve growth factor on patients with severe craniocerebral injury[J].,2018,(04):479.[doi:10.13798/j.issn.1009-153X.2018.07.009]
[9]徐　阳　刘宝辉　袁凡恩　刘骏辉　许鹏飞　陈谦学.小胶质细胞在缺血性脑卒中中作用机制的研究进展[J].中国临床神经外科杂志,2018,(07):503.[doi:10.13798/j.issn.1009-153X.2018.07.020]
[10]秦海林　秦　汉　安学锋　別毕洲.颈动脉内膜斑块剥脱术治疗颈内动脉重度狭窄[J].中国临床神经外科杂志,2018,(12):775.[doi:10.13798/j.issn.1009-153X.2018.12.003]
　QIN Hai-lin,QIN Han,AN Xue-feng,et al.Effect of carotid endarterectomy on patients with severe stenosis of internal carotid artery[J].,2018,(04):775.[doi:10.13798/j.issn.1009-153X.2018.12.003]

备注/Memo

备注/Memo:

通讯作者：王云甫，E-amil：wangxl3359@163.com
更新日期/Last Update: 2017-04-25